Latest News
Featured News
Scancell to present positive Phase 2 data on Immunobody® iSCIB1+ in late-stage melanoma at SITC 2025
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell to present positive Phase 2 data on Immunobody® iSCIB1+ in late-stage melanoma at SITC 2025
Results of 2025 Annual General Meeting
Notice of Annual General Meeting
Director Dealing
Preliminary Results for the Year Ended 30 April 2025
Notice of Results
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.
